Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +742.64%
#3 ADO Protocol ADO Protocol +103.82%
#4 Cortex Cortex +95.56%
#5 Ontology Gas Ontology Gas +85.65%
#6 Kinesis Silver Kinesis Silver +53.16%
#7 Magma Finance Magma Finance +30.19%
#8 OpenEden OpenEden +29.92%
#9 PondCoin PondCoin +27.37%
#10 Pons Pons +24.66%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Rang in aandelen #18664
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Aandeelprijs
$0.15360289
Marktkapitalisatie
$190.75M
Verandering (1 dag)
6.25%
Verandering (1 jaar)
94.11%
Land
NZ
Handel Pacific Edge Limited (PEB)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Pacific Edge Limited (PEB)
Het dividendrendement (TTM) van Pacific Edge Limited (aandelsymbool: PEB) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Pacific Edge Limited (PEB) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
0.31%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
0.71%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
0.68%
US